Table 1.

Prevalence of HPV, cervical intraepithelial neoplasia grade 2 or worse (CIN2+) and sensitivity and specificity of HPV testing by HIV status

	Women without HIV	Women living with HIV
Mean age in years (standard deviation)	44.01 (9.24)	40.30 (7.08)
N in screening population	349	307
Prevalence of any high-risk HPV	16.62 (12.71 – 20.52)	48.21 (42.62 – 53.80)
Prevalence of HPV 3 channels detecting HPV 16, 18, 45, 31, 33, 35, 52, 58	13.75 (10.14 – 17.37)	42.02 (36.50 – 47.54)
Prevalence of CIN2+	5.16 (2.84 – 7.48)	16.29 (12.16 – 20.42)
N without CIN2+ in the screening population	331	257
Specificity in screening population of any high-risk HPV	86.40 (82.71 – 90.10)	59.92 (53.93 – 65.91)
Specificity of HPV 3 channels detecting HPV 16, 18, 45, 31, 33, 35, 52, 58	89.43 (86.11 – 92.74)	66.93 (61.17 – 72.68)
N with CIN2+ screening and referral population	85	166
Sensitivity of any high-risk HPV	88.24 (81.39 – 95.08)	93.37 (89.59 – 97.16)
Sensitivity of HPV 3 channels detecting HPV 16, 18, 45, 31, 33, 35, 52, 58	87.06 (79.92 – 94.19)	91.57 (87.34 – 95.79)